NCT01720563 2025-06-04
A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concurrent Chemoradiotherapy
PhytoHealth Corporation
Phase 2 Terminated
PhytoHealth Corporation
BeiGene
Celgene
Merck KGaA, Darmstadt, Germany
Eli Lilly and Company